The annual MIT Startup Ecosystem Conference features 25 of the most promising startups from across MIT. These startups are all part of STEX25, an accelerator run by MIT Startup Exchange, an integrated program of MIT Corporate Relations.
On top of “business-as-usual”, company leaders must face very complex and uncertain geopolitical and macroeconomic challenges, particularly for global companies. Some of the macroeconomic uncertainties these leaders have to overcome are inflation, rising interest rates, and fear of recession. Businesses also have to deal with the diversification of its supply chains and potential relocation of manufacturing plants, energy supply restrictions and cybersecurity risks, while reaching its business, equity and sustainability goals. Join us to hear from MIT faculty and MIT Startup Exchange entrepreneurs to learn about their views on how to deal with some of these pressing issues, lead creatively and innovate in times of uncertainty.
Do you have an innovative solution to a problem in healthcare or biotech? The Sloan Healthcare Innovation Prize (SHIP) is MIT’s premier pitch competition for early-stage healthcare startups.
P&G is looking to drive agile in-market pilots in Europe with the goal of scaling successful services & solutions.
Amgen launches 2020 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
P&G Ventures is looking for solutions to help men age with vitality and live their fullest lives.
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio